156 related articles for article (PubMed ID: 8655211)
1. Incidence and mechanisms of aminoglycoside resistance in Pseudomonas aeruginosa serotype O11 isolates.
Kettner M; Milosovic P; Hletková M; Kallová J
Infection; 1995; 23(6):380-3. PubMed ID: 8655211
[TBL] [Abstract][Full Text] [Related]
2. Role of Aminoglycoside-Modifying Enzymes (AMEs) in Resistance to Aminoglycosides among Clinical Isolates of
Ahmadian L; Norouzi Bazgir Z; Ahanjan M; Valadan R; Goli HR
Biomed Res Int; 2021; 2021():7077344. PubMed ID: 34471641
[TBL] [Abstract][Full Text] [Related]
3. Aminoglycoside resistance in Pseudomonas aeruginosa isolated from cystic fibrosis patients.
McNeill WF; John JF; Twitty JA
Am J Clin Pathol; 1984 Jun; 81(6):742-7. PubMed ID: 6428216
[TBL] [Abstract][Full Text] [Related]
4. Aminoglycoside resistance mechanisms in clinical isolates of Pseudomonas aeruginosa from the Canary Islands.
Rodríguez Esparragón F; González Martín M; González Lama Z; Sabatelli FJ; Tejedor Junco MT
Zentralbl Bakteriol; 2000 Jan; 289(8):817-26. PubMed ID: 10705613
[TBL] [Abstract][Full Text] [Related]
5. Resistance mechanisms of multiresistant serotype 012 Pseudomonas aeruginosa isolated in Europe.
Pitt TL; Livermore DM; Miller G; Vatopoulos A; Legakis NJ
J Antimicrob Chemother; 1990 Sep; 26(3):319-28. PubMed ID: 2121698
[TBL] [Abstract][Full Text] [Related]
6. Serotypes and extended spectrum beta-lactam resistance in aminoglycoside resistant Pseudomonas aeruginosa isolates from two Belgian general hospitals: a seven year study.
Vanhoof R; Godard C; Nulens E; Nyssen HJ; Wildemauwe C; Hubrechts JM; Maes P; Hannecart-Pokorni E
J Hosp Infect; 1993 Jun; 24(2):129-38. PubMed ID: 8104976
[TBL] [Abstract][Full Text] [Related]
7. The most frequently occurring aminoglycoside resistance mechanisms--combined results of surveys in eight regions of the world. The Aminoglycoside Resistance Study Groups.
J Chemother; 1995 Jun; 7 Suppl 2():17-30. PubMed ID: 8622108
[TBL] [Abstract][Full Text] [Related]
8. Beta-lactam and aminoglycoside resistance rates and mechanisms among Pseudomonas aeruginosa in French general practice (community and private healthcare centres).
Dubois V; Arpin C; Dupart V; Scavelli A; Coulange L; André C; Fischer I; Grobost F; Brochet JP; Lagrange I; Dutilh B; Jullin J; Noury P; Larribet G; Quentin C
J Antimicrob Chemother; 2008 Aug; 62(2):316-23. PubMed ID: 18467306
[TBL] [Abstract][Full Text] [Related]
9. The prevalence of aminoglycoside-modifying enzyme genes (aac (6')-I, aac (6')-II, ant (2")-I, aph (3')-VI) in Pseudomonas aeruginosa.
Vaziri F; Peerayeh SN; Nejad QB; Farhadian A
Clinics (Sao Paulo); 2011; 66(9):1519-22. PubMed ID: 22179152
[TBL] [Abstract][Full Text] [Related]
10. Resistance due to aminoglycoside modifying enzymes in Pseudomonas aeruginosa isolates from burns patients.
Shahid M; Malik A
Indian J Med Res; 2005 Oct; 122(4):324-9. PubMed ID: 16394325
[TBL] [Abstract][Full Text] [Related]
11. Transferable amikacin resistance in gram-negative bacterial isolates.
Kallová J; Macicková T; Majtánová A; Aghová A; Adam D; Kettner M
Chemotherapy; 1995; 41(3):187-92. PubMed ID: 7656664
[TBL] [Abstract][Full Text] [Related]
12. The major aminoglycoside-modifying enzyme AAC(3)-II found in Escherichia coli determines a significant disparity in its resistance to gentamicin and amikacin in China.
Xiao Y; Hu Y
Microb Drug Resist; 2012 Feb; 18(1):42-6. PubMed ID: 22066787
[TBL] [Abstract][Full Text] [Related]
13. AMINOGLYCOSIDE RESISTANCE GENES IN Pseudomonas aeruginosa ISOLATES FROM CUMANA, VENEZUELA.
Teixeira B; Rodulfo H; Carreño N; Guzmán M; Salazar E; De Donato M
Rev Inst Med Trop Sao Paulo; 2016; 58():13. PubMed ID: 27007556
[TBL] [Abstract][Full Text] [Related]
14. The resistance patterns and serotypes of Pseudomonas aeruginosa strains isolated from children.
Patzer J; Dzierzanowska D
J Antimicrob Chemother; 1991 Dec; 28(6):869-75. PubMed ID: 1816183
[TBL] [Abstract][Full Text] [Related]
15. Pseudomonas aeruginosa resistant to aminoglycosides: an assessment of the currently used methods of disk diffusion and dilution susceptibility.
Ismaeel NA
Microbios; 1991; 66(268-269):197-204. PubMed ID: 1907714
[TBL] [Abstract][Full Text] [Related]
16. Characterization of Class 1 integrons from Pseudomonas aeruginosa that contain the bla(VIM-2) carbapenem-hydrolyzing beta-lactamase gene and of two novel aminoglycoside resistance gene cassettes.
Poirel L; Lambert T; Türkoglü S; Ronco E; Gaillard J; Nordmann P
Antimicrob Agents Chemother; 2001 Feb; 45(2):546-52. PubMed ID: 11158753
[TBL] [Abstract][Full Text] [Related]
17. Dissemination of aminoglycoside-modifying enzymes and 16S rRNA methylases among acinetobacter baumannii and Pseudomonas aeruginosa isolates.
Aghazadeh M; Rezaee MA; Nahaei MR; Mahdian R; Pajand O; Saffari F; Hassan M; Hojabri Z
Microb Drug Resist; 2013 Aug; 19(4):282-8. PubMed ID: 23577624
[TBL] [Abstract][Full Text] [Related]
18. [In vitro sensitivity at 18 antibiotics of 192 strains of Pseudomonas aeruginosa isolated at Garches Hospital].
Ronco E; Vacheron F; Orabona A
Pathol Biol (Paris); 1987 May; 35(5):558-62. PubMed ID: 3112708
[TBL] [Abstract][Full Text] [Related]
19. [The role of aminoglycoside--modifying enzymes in resistance of Gram-negative rods].
Jakoniuk P; Wieczorek P; Sacha PT; Zalewska M; Leszczyńska K
Med Dosw Mikrobiol; 2006; 58(4):363-70. PubMed ID: 17642314
[TBL] [Abstract][Full Text] [Related]
20. Occurrence of aminoglycoside-modifying enzymes genes (aac(6')-I and ant(2″)-I) in clinical isolates of Pseudomonas aeruginosa from Southwest Nigeria.
Odumosu BT; Adeniyi BA; Chandra R
Afr Health Sci; 2015 Dec; 15(4):1277-81. PubMed ID: 26958031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
